Project duration: 1 Year
|
|
|
|
Each year, twice as many women die in childbirth as people who died in the 2004 tsunami. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but we have shown that traditional midwives can use inexpensive misoprostol tablets to save lives in a woman’s home. This is where most births take place and most maternal deaths occur in the developing world--well beyond reach of hospitals and government health services.
|
|
|
|
We help create a sustainable market for misoprostol by working with local businesses who resell it at a small profit. We work with manufacturers, assist with the regulatory process, co-sponsor policy meetings and develop educational materials. |
|
|
|
The project is uniquely scalable. Tanzania has been unable to lower maternal death rates to meet the U.N.'s 2015 goal of 75% reduction. With this drug, traditional midwives get their first effective technology and see a major reduction in mortality. |
|
|
When we started training for the Kigoma project, word spread. Pregnant women who knew their lives were in danger traveled 70km when they heard that we had a drug to stop bleeding after childbirth.
- Dr. Ndola Prata, advisor, Tanzania study with traditional midwives
|
Amy Grossman,
Project contact
Venture Strategies 2140 Shattuck Avenue, Suite 1110 Berkeley, CA 94704-1234
United States
510-665-1880
|
|
|
|
|